NOTE. Percentage values in the cells may not sum up to 100% because of rounding. Bold indicates P < .05. Abbreviations: Bev, bevacizumab; ECOG-PS, Eastern Cooperative Oncology Group Performance Status ...
Hosted on MSN
EGF skincare is being hailed as the new retinol - but what is it, and how does it work?
EGF in skincare has been teetering on the edge of becoming the ‘next big thing’ for a while now. Premium brands have been working with epidermal growth factors (EGF) for a long time, but the ...
HER2 has emerged as a significant biomarker in UC, holding considerable therapeutic implications. Given the tumor-agnostic approval of T-DXd for patients with HER2 IHC 3+ expression, all patients with ...
A guide for patients to understand HER2-positive breast cancer, treatment options by stage and how to talk with your oncologist.
Pharmaceutical Technology on MSN
FDA approves Lilly’s Inluriyo to treat advanced breast cancer
Eli Lilly and Company (Lilly) has received approval from the US Food and Drug Administration (FDA) for Inluriyo (imlunestrant ...
Eli Lilly secured FDA approval for breast cancer drug Inluriyo and EU clearance for Alzheimer's therapy Kisunla following ...
The US Food and Drug Administration (FDA) yesterday approved Eli Lilly’s Inluriyo (imlunestrant, 200mg tablets), an oral ...
Eli Lilly and Co.’s oral selective estrogen receptor degrader (SERD) imlunestrant has been approved by the U.S. FDA for ...
The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback